Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest Update

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) was the target of a large decline in short interest in February. As of February 27th, there was short interest totaling 10,141 shares, a decline of 50.5% from the February 12th total of 20,471 shares. Based on an average daily trading volume, of 18,389 shares, the short-interest ratio is presently 0.6 days. Approximately 0.4% of the shares of the stock are sold short. Approximately 0.4% of the shares of the stock are sold short. Based on an average daily trading volume, of 18,389 shares, the short-interest ratio is presently 0.6 days.

Invesco Nasdaq Biotechnology ETF Stock Performance

NASDAQ IBBQ traded down $0.13 during trading hours on Friday, reaching $28.46. The company’s stock had a trading volume of 4,261 shares, compared to its average volume of 41,324. The company’s 50-day moving average is $29.32 and its two-hundred day moving average is $27.41. Invesco Nasdaq Biotechnology ETF has a fifty-two week low of $17.84 and a fifty-two week high of $30.49. The stock has a market cap of $71.43 million, a PE ratio of 17.03 and a beta of 0.67.

Invesco Nasdaq Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 26th. Shareholders of record on Monday, December 22nd were issued a $0.0906 dividend. This represents a $0.36 annualized dividend and a dividend yield of 1.3%. The ex-dividend date of this dividend was Monday, December 22nd.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of IBBQ. Royal Bank of Canada purchased a new stake in Invesco Nasdaq Biotechnology ETF in the 4th quarter valued at approximately $37,000. International Assets Investment Management LLC purchased a new position in Invesco Nasdaq Biotechnology ETF during the fourth quarter worth $41,000. MMA Asset Management LLC purchased a new position in Invesco Nasdaq Biotechnology ETF during the third quarter worth $51,000. Advisory Services Network LLC acquired a new position in shares of Invesco Nasdaq Biotechnology ETF in the third quarter worth $52,000. Finally, Osaic Holdings Inc. raised its holdings in shares of Invesco Nasdaq Biotechnology ETF by 28.4% in the second quarter. Osaic Holdings Inc. now owns 4,757 shares of the company’s stock worth $101,000 after acquiring an additional 1,052 shares during the last quarter.

Invesco Nasdaq Biotechnology ETF Company Profile

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.